Abstract：
OBJECTIVE: To determine the prevalence of erectile lower urinary tract symptoms in hypertensive patients, cardiovascular risk and the impact on quality of life.
METHODS: Setting: Health Center (Vilagarcia, Pontevedra).
METHODS: April 2015-June 2017.
METHODS: Hypertensive patient with informed consent.
METHODS: sociodemographic variables, toxic habits, comorbidity, blood pressure, cardiovascular risk, analytical and examination parameters. Questionaries: International Prostate Symptom Scale (IPSS), International Index of Erectile Function (IIEF-15) and quality of life in arterial hypertension (MINICHAL).
METHODS: n=262 (± 6% accuracy, 95% confidence).
METHODS: Bivariate and multivariate statistical analysis. Informed consent and ethics committee approval were obtained (2024/237) RESULTS: The mean age was 65.84 (12.70), and mean hypertension duration of 13.25 (9.84) years. 76.7% reported lower tract urinary symptoms, 91.6% being mild. The bivariate analysis showed an association with the variables: age, educational level, profession, work activity, tobacco, benign prostatic hypertrophy, years of diagnosis, concomitant medication, Framingham-Wilson score, electrocardiogram, glycated hemoglobin, glomerular filtration (Crockroft-Gault), LDL-cholesterol, somatic manifestations (MINICHAL), erectile dysfunction. The multivariate analysis showed increased risk with:abdominal obesity, pathological electrocardiogram, high risk of Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents and decreased with not smoking and use diuretics.
CONCLUSIONS: Three quarters of hypertensive men presented lower urinary tract symptoms, increasing the risk of cardiovascular disease early according to the Framingham-Wilson score. Other predictive factors were: abdominal obesity, tobacco, pathological electrocardiogram, high Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents.
METHODS: Setting: Health Center (Vilagarcia, Pontevedra).
METHODS: April 2015-June 2017.
METHODS: Hypertensive patient with informed consent.
METHODS: sociodemographic variables, toxic habits, comorbidity, blood pressure, cardiovascular risk, analytical and examination parameters. Questionaries: International Prostate Symptom Scale (IPSS), International Index of Erectile Function (IIEF-15) and quality of life in arterial hypertension (MINICHAL).
METHODS: n=262 (± 6% accuracy, 95% confidence).
METHODS: Bivariate and multivariate statistical analysis. Informed consent and ethics committee approval were obtained (2024/237) RESULTS: The mean age was 65.84 (12.70), and mean hypertension duration of 13.25 (9.84) years. 76.7% reported lower tract urinary symptoms, 91.6% being mild. The bivariate analysis showed an association with the variables: age, educational level, profession, work activity, tobacco, benign prostatic hypertrophy, years of diagnosis, concomitant medication, Framingham-Wilson score, electrocardiogram, glycated hemoglobin, glomerular filtration (Crockroft-Gault), LDL-cholesterol, somatic manifestations (MINICHAL), erectile dysfunction. The multivariate analysis showed increased risk with:abdominal obesity, pathological electrocardiogram, high risk of Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents and decreased with not smoking and use diuretics.
CONCLUSIONS: Three quarters of hypertensive men presented lower urinary tract symptoms, increasing the risk of cardiovascular disease early according to the Framingham-Wilson score. Other predictive factors were: abdominal obesity, tobacco, pathological electrocardiogram, high Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents.
摘要：
目的：确定高血压患者勃起下尿路症状的患病率，心血管风险和对生活质量的影响。
方法：设置：健康中心（Vilagarcia，Pontevedra）。
方法：2015年4月至2017年6月。
方法：高血压患者知情同意。
方法：社会人口统计学变量，有毒的习惯,合并症，血压,心血管风险，分析和检查参数。问卷：国际前列腺症状量表（IPSS），国际勃起功能指数（IIEF-15）和动脉高血压生活质量（MINICHAL）。
方法：n=262（精度±6％，95%置信度)。
方法：双变量和多变量统计分析。获得知情同意和伦理委员会批准（2024/237）结果：平均年龄为65.84（12.70），平均高血压病程13.25(9.84)年。76.7％报告了下尿路症状，91.6%为轻度。双变量分析显示与以下变量相关：年龄，教育水平,职业,工作活动,烟草,良性前列腺肥大,多年的诊断，合并用药,弗雷明汉-威尔逊得分,心电图,糖化血红蛋白,肾小球滤过（Crockroft-Gault），LDL-胆固醇,躯体表现(MINICHAL)，勃起功能障碍。多变量分析显示风险增加：腹型肥胖，病理性心电图,弗雷明汉-威尔逊得分的高风险，勃起功能障碍,使用催血药和减少与不吸烟和使用利尿剂。
结论：四分之三的高血压男性出现下尿路症状，根据Framingham-Wilson评分，早期增加心血管疾病的风险。其他预测因素有：腹部肥胖，烟草,病理性心电图,弗雷明汉-威尔逊得分很高,勃起功能障碍,使用催血剂。
方法：设置：健康中心（Vilagarcia，Pontevedra）。
方法：2015年4月至2017年6月。
方法：高血压患者知情同意。
方法：社会人口统计学变量，有毒的习惯,合并症，血压,心血管风险，分析和检查参数。问卷：国际前列腺症状量表（IPSS），国际勃起功能指数（IIEF-15）和动脉高血压生活质量（MINICHAL）。
方法：n=262（精度±6％，95%置信度)。
方法：双变量和多变量统计分析。获得知情同意和伦理委员会批准（2024/237）结果：平均年龄为65.84（12.70），平均高血压病程13.25(9.84)年。76.7％报告了下尿路症状，91.6%为轻度。双变量分析显示与以下变量相关：年龄，教育水平,职业,工作活动,烟草,良性前列腺肥大,多年的诊断，合并用药,弗雷明汉-威尔逊得分,心电图,糖化血红蛋白,肾小球滤过（Crockroft-Gault），LDL-胆固醇,躯体表现(MINICHAL)，勃起功能障碍。多变量分析显示风险增加：腹型肥胖，病理性心电图,弗雷明汉-威尔逊得分的高风险，勃起功能障碍,使用催血药和减少与不吸烟和使用利尿剂。
结论：四分之三的高血压男性出现下尿路症状，根据Framingham-Wilson评分，早期增加心血管疾病的风险。其他预测因素有：腹部肥胖，烟草,病理性心电图,弗雷明汉-威尔逊得分很高,勃起功能障碍,使用催血剂。
